Renal Flashcards
Elevation of blood urea nitrogen and creatinine levels with dec GFR
Azotemia
Hypoperfusion of kidneys
Dec GFR
No parenchymal damage
Prerenal azotemia
Obstruction of urine flow below kidney
Relief of obstruction followed by azotemia
Postrenal azotemia
Azotemia with clinical symptoms and biochem abnormalities
Uremia
Glomerular injury acute onset of visible hematuria proteinuria azotemia edema hypertension
Nephritis
Poststreptococcal glomerulonephritis
Heavy proteinuria >3.5g per day, hypoalbuminemia
severe edema
hyperlipidemia
lipiduria
Nephrotic syndrome
Crucial to maintenance of glomerular barrier function as diffusion barrier
Podocyte
Also synthesize GBM components
transmembrane glycoprotein of the slit diaphragms between adjacent foot processes
Nephrin
Maintains selective permeability of filtration barrier along with nephrin
Podocin
Systemic and immunologically mediated diseases affecting glomerules
(SLE, Alport, DM, HUS)
Secondary glomerular disease
Two forms of antibody assoc injury in glomerulonephritis:
1 deposition of soluble circulating antigen-antibody complex in glomerulus
2 antibodies reacting in situ within glomerulus
pathogens that incite GN
1 streptococcal
2 Hepatitis B
3 Plasmodium falciparum malaria
4 Spirochetal
Antigen-antibody complex producing injury through activation of complement and recruitment of leukocyte
Glomerulonephritis by immune complex
Electron microscopy of GN show immune complexes on (4)
Mesangium Subendothelial (bet endothelial and GBM) Subepithelial (bet outer GBM and podocyte)
Complexes in endothelium and subendothelium elicit
Inflammatory reaction from infiltration of leukocyte and proliferation of glomerular cell
Antibodies directed at subepithelial region of glomerulus produce
Noninflammatory lesions similar to Heymann nephritis or membranous nephropathy
Antibodies directed fixed antigen in GBM
LINEAR pattern of staining
Conformational change in alpha3 chain of type IV collagen in GBM
Anti-glomerular basement membrane Antibody-mediated crescentic Glomerulonephritis
Complication/sequelae of Anti-GBM Antibody-mediated GN with antibodies also cross reacting with basement membrane of lung alveoli
Goodpasture syndrome
simultaneous lung and kidney lesions
Immune injury on Glomerulus pathophy
Complement activation via classical pathway:
Chemotactic agents C5a for neutrophil and monocyte
Protease release from neutrophils causing GBM degradation
O2 radical generation causing damage
Arachidonic acid metab causing dec GFR
Antibody mediated GN show this type of pattern desposition
Granular
Immune complex antibodies cause injury by
1 complement activation
2 leukocyte recruitment with mediator release sometimes damaging podocyte
Nephrotic syndrome clinical complex (4)
1 massive proteinuria >3.5g/day
2 hypoalbuminemia <3g/dL
3 Generalized edema
4 hyperlipidemia and lipiduria
Hyperlipidemia in nephrotic syndrome is caused by
Inc release of lipoproteins in liver or
Loss of lipoprotein synthesis inhibitors
Most common cause of primary glomerular disease nephrotic in children
Minimal-change disease 65%
Most common cause of primary glomerular disease nephrotic in adults
Focal segmental glomerulosclerosis 35%
Membranous nephropathy 30%
Primary nephrotic renal disease occurs
95% in children
In adults, primary nephrotic disease is caused by
Renal manifestation of systemic disease 40%
Glomeruli have normal appearance by light microscopy but show uniform diffuse effacement of podocyte foot processes on EM
Common at ages 1-7
Minimal change disease
90% of children respond to a short course of corticosteroid therapy
MCD
2/3 will have recurrence of proteinuria
FSGS may be secondary attributed to (5)
HIV Heroin IgA nephropathy 2 event Maladaptation to nephron loss Mutation in cytoskeletal proteins and podocin for integrity of podocyte and variant in apolopoprotein L1 gene APOL1 on chromosome 22
Injury to podocyte as initiating event
First affects some of glomeruli of JM
Lesions occuring in some tufts within a glomerulus and sparing of others
Inc mesangial matrix, obliterated capillary lumina, deposition of hyaline masses and lipid droplets
Focal segmental glomerulosclerosis
Collapse of glomerular tuft and podocyte hyperplasia
Poor prognosis
Collapsing glomerulopathy
Hematuria
Hypertension
Non selective proteinuria
Poor response to corticosteroid
Focal segmental glomerulosclerosis
Subepithelial IgG deposit along GBM
Diffuse thickening of capillary wall
Chronic immune complex GN by antibodies against glomerular Ag.
Without inflammation
Membranous nephropathy
Antigen most commonly recognized by causative antibodies in MN
Phospholipase A2
Spike and dome pattern
with granular deposits
Membranous nephropathy
MN may be caused by inciting events such as (5)
Infection Hep B, syphilis, schistosomiasis, malaria Malignancy CA of Lung, colon melanoma SLE Inorganic salt gold and mercury exposure Drugs (Penicillamine, captopril, NSAID)
Full blown nephrotic syndrome without antecedent illness
Non-selective proteinuria
Not responsive to corticosteroid
Protein in 60%
Membranous nephropathy
Caused by circulating immune complex or planted antigen with in situ complex
Assoc with Hepa B and C antigen, SLE, AV shunt
MPGN Type I
Excess compliment activation against C3 convertase or nephritic factor that lead to uncontrolled activation of alternative complement
MPGN Type II
Dense deposit disease
MPGN Type II is associated with mutations in gene encoding complent regulatory factor protein
factor H
Hypocomplementemia is marked in MPGN Type II due to
excessive consumption of C3 and reduced synthesis by liver
Glomeruli with lobular appearance, proliferation of mesangial and endothelial cell and infiltrating leukocytes
GBM thickening
MPGN
Tram track or double contour capillary wall
Splitting of GBM
MPGN
subendothelial electron dense immune deposit
C3 in irregular pattern
Type I MPGN
Irregular, ribbon-like lamina densa and subendothelial space from unknown composition
C3 present in irregular chunky segmental linear foci
Complement dysregulation
Dense deposit disease
Poor prognosis recurring in transplant patients
MPGN type II
Underlying mechanism of proteinuria from immune and nonimmune causes
Podocyte injury
Nephritic syndrome complex
1 hematuria
2 oliguria and azotemia
3 hypertension
Glomerular deposition of immune complexes resulting in proliferation and damage to glomerular cells and infiltration of leukocytes esp neutrophils
Acute Postinfectious Poststreptococcal Glomerulonephritis
Others pathogens in Postinfectious GN
Pneumococcal Staph Mumps Measles Varicella Hep B, C
Inciting agent in Acute Postinfectious GN
Group A Beta Hemolytic Strep
Immune complex disease by complement activation of classical pathway
Hypocomplementemia
Granular deposits of IgG and complement on GBM
Poststrep GN
Antigen implicated in PSGN
Streptococcal exotoxin B (Spe B)
Streptococcal GAPDH
Increased cellularity of glomerular tuft (diffuse)
Infiltrating neutrophils and monocytes
Subendothelial, intramem or subepithelial humps of immune complexes against GBM
Granular deposits of IgG and complement cleared over 2 months
APSGN
Smoky brown gross hematuria Oliguria/Azotemia HTN Low complement Inc anti-streptolysin O
PSGN
Gross hematuria within 1-2d of URTI
Most common cause of recurrent microscopic or gross hematuria
IgA Nephropathy
Most common nephritic glomerular disease revealed by renal biopsy
Iga Nephropathy
Deposition of IgA in IgA nepropathy occurs in
mesangium
Systemic syndrome involving skin, GI, joints and kidneys with IgA deposition in mesangium
Henoch-Schonlein Purpura
Abnormality (inc) in IgA production and clearance
Antibodies against abnormally glycosylated IgA depositing in mesangium activating alternative complement pathway
IgA Nephropathy
Secondary IgA nephropathy occurs in
Celiac disease
Liver disease defective hepatobiliary clearance
Immunoflorescence shows mesangial deposition of IgA with C3 either focal, diffuse or over crescentic
IgA nephropathy